메뉴 건너뛰기




Volumn 86, Issue 1, 2015, Pages 45-49

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM CARBONATE; PLACEBO;

EID: 84919778206     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-306865     Document Type: Article
Times cited : (75)

References (31)
  • 1
    • 79952486262 scopus 로고    scopus 로고
    • Amyotrophic lateral sclerosis
    • Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942-55.
    • (2011) Lancet , vol.377 , pp. 942-955
    • Kiernan, M.C.1    Vucic, S.2    Cheah, B.C.3
  • 2
    • 84857537860 scopus 로고    scopus 로고
    • A proposed staging system for amyotrophic lateral sclerosis
    • Roche JC, Rojas-Garcia R, Scott KM, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain 2012;135(Pt 3):847-52.
    • (2012) Brain , vol.135 , pp. 847-852
    • Roche, J.C.1    Rojas-Garcia, R.2    Scott, K.M.3
  • 3
    • 84901494031 scopus 로고    scopus 로고
    • Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis
    • Jones A, Jivraj N, Balendra R, et al. Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2014. doi:10.3109/21678421.2013.872149
    • (2014) Amyotroph Lateral Scler Frontotemporal Degener
    • Jones, A.1    Jivraj, N.2    Balendra, R.3
  • 4
    • 77949314446 scopus 로고    scopus 로고
    • Motor neuron disease: The bare essentials
    • Talbot K. Motor neuron disease: the bare essentials. Pract Neurol 2009;9:303-9.
    • (2009) Pract Neurol , vol.9 , pp. 303-309
    • Talbot, K.1
  • 5
    • 0038480212 scopus 로고    scopus 로고
    • Prolonged survival in motor neuron disease: A descriptive study of the King's database 1990-2002
    • Turner MR, Parton MJ, Shaw CE, et al. Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002. J Neurol Neurosurg Psychiatry 2003;74:995-7.
    • (2003) J Neurol Neurosurg Psychiatry , vol.74 , pp. 995-997
    • Turner, M.R.1    Parton, M.J.2    Shaw, C.E.3
  • 6
    • 85015507759 scopus 로고    scopus 로고
    • A Phase 2 - 3 trial of olesoxime in subjects with amyotrophic lateral sclerosis, 23rd International Symposium on ALS/MND Abstracts
    • A Phase 2 - 3 trial of olesoxime in subjects with amyotrophic lateral sclerosis, 23rd International Symposium on ALS/MND Abstracts. Amyotroph Lateral Scler 2012;13 (S1):1-58.
    • (2012) Amyotroph Lateral Scler , vol.13 , Issue.S1 , pp. 1-58
  • 7
    • 80053175592 scopus 로고    scopus 로고
    • Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS)
    • Eudract number: 2008-006891-31
    • Al-Chalabi A, Shaw PJ, Young CA, et al. Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31]. BMC Neurol 2011;11:111.
    • (2011) BMC Neurol , vol.11 , pp. 111
    • Al-Chalabi, A.1    Shaw, P.J.2    Young, C.A.3
  • 8
    • 84875273042 scopus 로고    scopus 로고
    • Lithium in patients with amyotrophic lateral sclerosis (LiCALS): A phase 3 multicentre, randomised, double-blind, placebo-controlled trial
    • Lithium in patients with amyotrophic lateral sclerosis (LiCALS): A phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2013;12:339-45.
    • (2013) Lancet Neurol , vol.12 , pp. 339-345
  • 9
    • 0034574407 scopus 로고    scopus 로고
    • El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
    • Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2000;1:293-9.
    • (2000) Amyotroph Lateral Scler , vol.1 , pp. 293-299
    • Brooks, B.R.1    Miller, R.G.2    Swash, M.3
  • 10
    • 0032692481 scopus 로고    scopus 로고
    • The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)
    • Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
    • (1999) J Neurol Sci , vol.169 , pp. 13-21
    • Cedarbaum, J.M.1    Stambler, N.2    Malta, E.3
  • 11
    • 84873902183 scopus 로고    scopus 로고
    • New considerations in the design of clinical trials for amyotrophic lateral sclerosis
    • Berry JD, Cudkowicz ME. New considerations in the design of clinical trials for amyotrophic lateral sclerosis. Clin Invest 2011;1:1375-89.
    • (2011) Clin Invest , vol.1 , pp. 1375-1389
    • Berry, J.D.1    Cudkowicz, M.E.2
  • 13
    • 70450158934 scopus 로고    scopus 로고
    • The natural history of ALS is changing: Improved survival
    • Qureshi M, Schoenfeld DA, Paliwal Y, et al. The natural history of ALS is changing: Improved survival. Amyotroph Lateral Scler 2009;10(5-6): 324-31.
    • (2009) Amyotroph Lateral Scler , vol.10 , Issue.5-6 , pp. 324-331
    • Qureshi, M.1    Schoenfeld, D.A.2    Paliwal, Y.3
  • 14
    • 33744809339 scopus 로고    scopus 로고
    • Clinical trials in ALS: What did we learn from recent trials in humans?
    • Meininger V. Clinical trials in ALS: what did we learn from recent trials in humans? Neurodegener Dis 2005;2(3-4):208-14.
    • (2005) Neurodegener Dis , vol.2 , Issue.3-4 , pp. 208-214
    • Meininger, V.1
  • 15
    • 47249154380 scopus 로고    scopus 로고
    • Therapy development for ALS: Lessons learned and path forward
    • Lanka V, Cudkowicz M. Therapy development for ALS: lessons learned and path forward. Amyotroph Lateral Scler 2008;9:131-40.
    • (2008) Amyotroph Lateral Scler , vol.9 , pp. 131-140
    • Lanka, V.1    Cudkowicz, M.2
  • 16
    • 0035015186 scopus 로고    scopus 로고
    • Clinical trials: Present and future
    • Mitsumoto H. Clinical trials: present and future. Amyotroph Lateral Scler 2001;2:S10-4.
    • (2001) Amyotroph Lateral Scler , vol.2 , pp. S10-S14
    • Mitsumoto, H.1
  • 17
    • 80755128213 scopus 로고    scopus 로고
    • Clinical diagnosis and management of amyotrophic lateral sclerosis
    • Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 2011;7:639-49.
    • (2011) Nat Rev Neurol , vol.7 , pp. 639-649
    • Hardiman, O.1    Van Den Berg, L.H.2    Kiernan, M.C.3
  • 18
    • 84919719348 scopus 로고    scopus 로고
    • Development of a clinical staging system for amyotrophic lateral sclerosis
    • (Meeting Abstracts 1):P07.071
    • Chio A, Hammond E, Mora G, et al. Development of a clinical staging system for amyotrophic lateral sclerosis. Neurology 2013;80(Meeting Abstracts 1):P07.071.
    • (2013) Neurology , vol.80
    • Chio, A.1    Hammond, E.2    Mora, G.3
  • 19
    • 0033905620 scopus 로고    scopus 로고
    • Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study
    • Traynor BJ, Codd MB, Corr B, et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study. Arch Neurol 2000;57:1171-6.
    • (2000) Arch Neurol , vol.57 , pp. 1171-1176
    • Traynor, B.J.1    Codd, M.B.2    Corr, B.3
  • 20
    • 79952199408 scopus 로고    scopus 로고
    • Progression in ALS is not linear but is curvilinear
    • Gordon PH, Cheng B, Salachas F, et al. Progression in ALS is not linear but is curvilinear. J Neurol 2010;257:1713-17.
    • (2010) J Neurol , vol.257 , pp. 1713-1717
    • Gordon, P.H.1    Cheng, B.2    Salachas, F.3
  • 21
    • 0033595524 scopus 로고    scopus 로고
    • Nutritional status is a prognostic factor for survival in ALS patients
    • Desport JC, Preux PM, Truong TC, et al. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999;53:1059-63.
    • (1999) Neurology , vol.53 , pp. 1059-1063
    • Desport, J.C.1    Preux, P.M.2    Truong, T.C.3
  • 22
    • 79955756864 scopus 로고    scopus 로고
    • Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients
    • Marin B, Desport JC, Kajeu P, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosur Psychiatry 2011;82:628-34.
    • (2011) J Neurol Neurosur Psychiatry , vol.82 , pp. 628-634
    • Marin, B.1    Desport, J.C.2    Kajeu, P.3
  • 23
    • 33744816556 scopus 로고    scopus 로고
    • Hypermetabolism in ALS: Correlations with clinical and paraclinical parameters
    • Desport JC, Torny F, Lacoste M, et al. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis 2005;2:202-7.
    • (2005) Neurodegener Dis , vol.2 , pp. 202-207
    • Desport, J.C.1    Torny, F.2    Lacoste, M.3
  • 24
    • 4544262980 scopus 로고    scopus 로고
    • Longitudinal analysis of progression of dysphagia in amyotrophic lateral sclerosis
    • Higo R, Tayama N, Nito T. Longitudinal analysis of progression of dysphagia in amyotrophic lateral sclerosis. Auris Nasus Larynx 2004;31:247-54.
    • (2004) Auris Nasus Larynx , vol.31 , pp. 247-254
    • Higo, R.1    Tayama, N.2    Nito, T.3
  • 26
    • 0024825916 scopus 로고
    • Bulbar amyotrophic lateral sclerosis: Patterns of progression and clinical management
    • Hillel AD, Miller R. Bulbar amyotrophic lateral sclerosis: patterns of progression and clinical management. Head Neck 1989;11:51-9.
    • (1989) Head Neck , vol.11 , pp. 51-59
    • Hillel, A.D.1    Miller, R.2
  • 27
    • 70350149848 scopus 로고    scopus 로고
    • Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the quality standards subcommittee of the American Academy of Neurology
    • Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1218-26.
    • (2009) Neurology , vol.73 , pp. 1218-1226
    • Miller, R.G.1    Jackson, C.E.2    Kasarskis, E.J.3
  • 28
    • 84866093307 scopus 로고    scopus 로고
    • What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis?
    • Pena MJ, Ravasco P, Machado M, et al. What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis? Amyotroph Lateral Scler 2012;13:550-4.
    • (2012) Amyotroph Lateral Scler , vol.13 , pp. 550-554
    • Pena, M.J.1    Ravasco, P.2    Machado, M.3
  • 29
    • 79952257244 scopus 로고    scopus 로고
    • Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease
    • Katzberg HD, Benatar M. Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2011;(1):CD004030.
    • (2011) Cochrane Database Syst Rev , Issue.1
    • Katzberg, H.D.1    Benatar, M.2
  • 30
    • 0141614836 scopus 로고    scopus 로고
    • Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction
    • Mitsumoto H, Davidson M, Moore D, et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler 2003;4:177-85.
    • (2003) Amyotroph Lateral Scler , vol.4 , pp. 177-185
    • Mitsumoto, H.1    Davidson, M.2    Moore, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.